SPRIM Tackles Peanut Allergy via Prota Therapeutics
18 Jan 2024
US$ 19.00
Singapore-based SPRIM Global Investments (SGI) has led the US$21 million equity and debt financing of Prota...
Tag
Biotech
Related Publications
APER Sep 2025 - Shifting Plates: Buyout in Japan...
Subscribers’ Weekly for the week ending 29 Aug 2025...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.